PAVM Dec 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:38AM EDT. Market open.
| Previous close | 0.4000 |
| Open | 0.4000 |
| Bid | 0.0000 |
| Ask | 3.6000 |
| Strike | 2.50 |
| Expiry date | 2024-12-20 |
| Day's range | 0.4000 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
- GuruFocus.com
PAVmed Inc (PAVM) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
Explore PAVmed Inc's strategic initiatives and financial performance, including a significant partnership with Ohio State's James Cancer Hospital and a robust Series B financing round.
PR NewswirePAVmed Provides Business Update and First Quarter 2024 Financial Results
PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the Company for the three months ended March 31, 2024.
© 2024 Yahoo. All rights reserved.